
Please try another search
Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S was founded in 2020 and is based in Copenhagen, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Adam Sinding Steensberg | 49 | 2020 | Independent Director |
Charlotte Videbaek | 63 | 2020 | Independent Director |
Rachel Curtis Gravesen | - | 2022 | Director |
Martin Olin Andersen | 56 | 2020 | Independent Chairman of the Board |
Flemming Steen Jensen | 64 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review